On June 4, Oscar Health rose 7.59% in regular trading, trading at $23.02/share, with trading volume of $52.94 million. The rally was driven by Wells Fargo upgrading the stock from Underweight to Equal Weight, with a significant price target increase from $11 to $20.

The upgrade sent a positive signal to the market, effectively offsetting negative sentiment from the June 2 announcement that co-founder and CTO Mario Schlosser transitioned out of his CTO role into an advisory position to the CEO. Given that Oscar Health is a technology-driven healthcare company built around a full-stack platform leveraging data and AI, the CTO departure had initially triggered concerns about the continuity of its tech strategy, pushing shares down over 5% on June 2. According to FactSet data, the stock currently carries an average analyst rating of Hold with a mean price target of $22.18.

Oscar Health operates as a health insurance company in the United States, offering Individual and Small Group, Medicare Advantage plans, and +Oscar, a technology-driven platform designed to help providers and payors shift to value-based care.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)